{"transactions":[{"id":1656573,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":94567,"kind":"person","name":"White Christopher G","position":1,"cik":"0001537668","reported_name":"White Christopher G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T23:38:53.000Z","date":"2024-02-03","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":120000,"derivative":{"exercise_price":5.18,"expiration_date":"2034-02-02","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001104659-24-011201","document":"tm245295-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465924011201/tm245295-5_4seq1.xml","form_type":"4"}},{"id":1656572,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":94567,"kind":"person","name":"White Christopher G","position":1,"cik":"0001537668","reported_name":"White Christopher G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-02-06T23:38:53.000Z","date":"2024-02-05","kind":"sale","planned":false,"acquired":true,"shares":5910,"price":4.86,"value":28722.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock of the Corporation sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 3, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.72 to $4.94, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":123689,"source":{"system":"sec-edgar","filing":"0001104659-24-011201","document":"tm245295-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465924011201/tm245295-5_4seq1.xml","form_type":"4"}},{"id":1656571,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":94567,"kind":"person","name":"White Christopher G","position":1,"cik":"0001537668","reported_name":"White Christopher G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-02-06T23:38:53.000Z","date":"2024-02-03","kind":"grant","planned":false,"acquired":true,"shares":39980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 3, 2024, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."}],"balance_after":129599,"source":{"system":"sec-edgar","filing":"0001104659-24-011201","document":"tm245295-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465924011201/tm245295-5_4seq1.xml","form_type":"4"}},{"id":1661027,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":94567,"kind":"person","name":"White Christopher G","position":1,"cik":"0001537668","reported_name":"White Christopher G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-02-03T00:01:26.000Z","date":"2024-01-31","kind":"sale","planned":false,"acquired":false,"shares":5147,"price":4.95,"value":25477.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 30, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 30, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.83 to $5.04, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":89619,"source":{"system":"sec-edgar","filing":"0001104659-24-010233","document":"tm245049-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465924010233/tm245049-2_4seq1.xml","form_type":"4"}},{"id":2026250,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":94567,"kind":"person","name":"White Christopher G","position":1,"cik":"0001537668","reported_name":"White Christopher G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-02-09T00:38:30.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":5829,"price":4.24,"value":24714.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 3, 2023. The reporting person structured the durable automatic sales instructions to constitute a \"binding contract\" consistent with the affirmative defense to liability under Rule 10b5-1. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 3, 2023. The reporting person structured the durable automatic sales instructions to constitute a \"binding contract\" consistent with the affirmative defense to liability under Rule 10b5-1. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.19 to $4.30, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":94766,"source":{"system":"sec-edgar","filing":"0001104659-23-014686","document":"tm235900-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465923014686/tm235900-2_4seq1.xml","form_type":"4"}},{"id":2038316,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":94567,"kind":"person","name":"White Christopher G","position":1,"cik":"0001537668","reported_name":"White Christopher G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T00:36:49.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":133333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":133333,"derivative":{"exercise_price":3.88,"expiration_date":"2033-01-29","underlying":"Common Stock","underlying_shares":133333},"source":{"system":"sec-edgar","filing":"0001104659-23-009418","document":"tm235116-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465923009418/tm235116-5_4seq1.xml","form_type":"4"}},{"id":2038315,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":94567,"kind":"person","name":"White Christopher G","position":1,"cik":"0001537668","reported_name":"White Christopher G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-02-02T00:36:49.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":44444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 30, 2023, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 94,444 shares of common stock of the Company underlying unvested RSUs and (ii) 4,024 shares of the Company's common stock acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan on December 31, 2022."}],"balance_after":100595,"source":{"system":"sec-edgar","filing":"0001104659-23-009418","document":"tm235116-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465923009418/tm235116-5_4seq1.xml","form_type":"4"}},{"id":2136903,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":94567,"kind":"person","name":"White Christopher G","position":1,"cik":"0001537668","reported_name":"White Christopher G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-15T01:04:25.000Z","date":"2022-10-13","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":7000,"derivative":{"exercise_price":4.19,"expiration_date":"2032-10-12","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001104659-22-108976","document":"tm2228232-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465922108976/tm2228232-1_4seq1.xml","form_type":"4"}},{"id":2409917,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":94567,"kind":"person","name":"White Christopher G","position":1,"cik":"0001537668","reported_name":"White Christopher G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-08T00:31:04.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":150000,"derivative":{"exercise_price":5.27,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-22-012920","document":"tm225652-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465922012920/tm225652-3_4seq1.xml","form_type":"4"}},{"id":2409916,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":94567,"kind":"person","name":"White Christopher G","position":1,"cik":"0001537668","reported_name":"White Christopher G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-02-08T00:31:04.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 3, 2022, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 50,000 shares of common stock of the Company underlying unvested RSUs and (ii) 2,127 shares of the Company's common stock acquired under the 2014 Ocular Therapuetix, Inc. Employee Stock Purchase Plan on December 31, 2021."}],"balance_after":52127,"source":{"system":"sec-edgar","filing":"0001104659-22-012920","document":"tm225652-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465922012920/tm225652-3_4seq1.xml","form_type":"4"}},{"id":2545312,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":94567,"kind":"person","name":"White Christopher G","position":1,"cik":"0001537668","reported_name":"White Christopher G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-08T20:34:07.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":10.37,"expiration_date":"2031-09-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-21-124656","document":"tm2129490-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465921124656/tm2129490-2_4seq1.xml","form_type":"4"}}]}